[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Integumen Plc LSE:SKIN London Ordinary Share GB00BMGWZY29 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 28.00 28.00 29.00 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Personal Goods 0.8 -2.4 0.3 93.3 32

Deepverge Equipment Selected for UK Covid-19 Infrastructure Trial

28/10/2021 11:28am

Dow Jones News


Integumen (LSE:SKIN)
Historical Stock Chart


From Jul 2021 to Jan 2022

Click Here for more Integumen Charts.

By Ian Walker

 

Deepverge PLC said Thursday that its enhanced monitoring equipment is to be installed as part of the U.K. Government's national Covid-19 infrastructure trial.

The environmental and life-sciences company said the equipment is worth 480,000 pounds ($659,520) and it expects to get revenue from installations next fiscal year, provided the trial is successful.

The trial is expected to last until the end of February 2022.

The multiple-unit installation consists of six upgraded Microtox toxicity monitoring and new models of the Microtox PD range for SARS-CoV-2 and other pathogen monitoring, Deepverge said.

"Deepverge is well-placed to capitalize on current and future opportunities to work with governments, industries bodies and private companies to create a co-ordinated solution, not only to the current global pandemic but also future health challenges," Chief Executive Gerry Brandon said.

Shares at 0952 GMT were up 2.25 pence, or 8.5%, at 28.75 pence.

 

Write to Ian Walker at ian.walker@wsj.com

 

(END) Dow Jones Newswires

October 28, 2021 06:13 ET (10:13 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Integumen Chart

1 Year Integumen Chart

1 Month Integumen Chart

1 Month Integumen Chart
ADVFN Advertorial
Your Recent History
LSE
SKIN
Integumen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220129 08:34:43